MEDICAL SALES & PROMOTION PRESENT AND FUTURE VISION Presented by - - PowerPoint PPT Presentation

medical sales promotion present and future vision
SMART_READER_LITE
LIVE PREVIEW

MEDICAL SALES & PROMOTION PRESENT AND FUTURE VISION Presented by - - PowerPoint PPT Presentation

Health Insight 4 PARTNERING FOR A BETTER FUTURE MEDICAL SALES & PROMOTION PRESENT AND FUTURE VISION Presented by Dr. SOHA SINNO, PharmD Sales Manager at Fresenius Medical Care, Lebanon Associate clinical Preceptor at BAU Secretary of


slide-1
SLIDE 1

Health Insight 4 PARTNERING FOR A BETTER FUTURE

MEDICAL SALES & PROMOTION PRESENT AND FUTURE VISION Presented by Dr. SOHA SINNO, PharmD Sales Manager at Fresenius Medical Care, Lebanon Associate clinical Preceptor at BAU Secretary of scientific committee at OPL

slide-2
SLIDE 2

Employed pharmacists distribution: Where do we stand today?

Order of Pharmacists Insights - March 27, 2014

slide-3
SLIDE 3

Shifting from commercial to scientific approach

slide-4
SLIDE 4

OPL Amendment: Where do we stand today?

 The OPL declared article number 73 in the law of

pharmacy practice in Lebanon in 1994 and being amended and reinforced in 2010.

 This amendment targets to improve the quality of

pharmacy practice in the field of marketing and promotions “only Pharmacists” are allowed to work in pharmaceutical companies.

 Strict application of this article will enhance the

  • pportunity for pharmacists to work in this field.

 The evolving role of Med Reps will encourage the freshly

graduated pharmacists to work in this field.

slide-5
SLIDE 5

Evolving Duties of a Pharmacist in the pharmaceutical companies

 Provide information in a transparent, accurate and timely

way to enable HCP to take advantage of what is achieved in medical science.

 Support continuing medical education of healthcare

professionals to disseminate the medical evidence characterising Pharmaceutical Products.

 Run Multicenter global and local clinical trials.  Process PharmacoVigilance reports, from physicians,

community &/or hospital Pharmacists.

 Abide by the different code of ethics, whichever is more

stringent.

slide-6
SLIDE 6

Safety and Pharmacovigilance

 Pharmacovigilance (PV) is defined as the science and

activities relating to the detection, assessment, understanding and prevention of adverse effects or any

  • ther Drug-Related Problem.

 At the end of 2010, 134 countries were part of the WHO

PV Program.

 The aim of PV is to enhance patient care and patient

safety in relation to the use of medicines; and to support public health programs by providing reliable, balanced information for the effective assessment of the risk- benefit profile of medicines. PHARMACISTS

slide-7
SLIDE 7

Ethical and Compliance

 The marketing of pharmaceutical products should be

highly regulated to comply with good marketing practices by adhering to applicable laws, regulations, industry codes and internal processes and standards established by the health authorities and pharmaceutical companies.

 Codes regarding good marketing practices include:

IFPMA*, PhRMA*

*IFPMA: International Federation of Pharmaceutical Manufacturers & Associations *PhRMA: Pharmaceutical Research and Manufacturers of America

slide-8
SLIDE 8

Future Insights

 Increased number of pharmacists

joining the pharmaceutical companies.

 The OPL projects the percentage to

increase from 43% to 50% within the few coming years.

slide-9
SLIDE 9

Future Insights

 Divers Career Pathways: Sales Marketing Medical

Order of Pharmacists Insights - March 27, 2014

slide-10
SLIDE 10

Career Pathway: Sales

Sales Manager Field Force Supervisor Product Specialist Medical representative

Order of Pharmacists Insights - March 27, 2014

slide-11
SLIDE 11

Career Pathway: Marketing

Marketing Manager Business Unit Manager Product Manager Medical representative

Order of Pharmacists Insights - March 27, 2014

slide-12
SLIDE 12

Career Pathway: Medical

Medical Manager Clinical Trial Manager Clinical Research Associate (CRA) Medical Science Liaison (MSL) Medical representative

Order of Pharmacists Insights - March 27, 2014

slide-13
SLIDE 13

THANK YOU

ACKNOWLEDGMENT TO:

  • MR. ABED AL RAHMAN SABRA, RPh, ROCHE Lebanon
  • OPL